아이빔테크놀로지

460470KOSDAQ

52.8 / 100

Reference Date: 2026-09-08

Financial Score18.5 / 40

News Sentiment21.3 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 9.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

AIBeam Technology develops and provides high-resolution in vivo microscopes, imaging accessories, and CRO services, enabling cellular-level analysis of internal organs and tissues in live animals. The company also offers AI-based medical devices for cancer diagnosis and precise tissue analysis.

Number of Employees

37people

Average Salary

39.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.54Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

-12.91Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

5.57Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20254.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲22.8% (1-year basis)

Operating Profit Growth Rate

1.0 / 3

Avg ▲3.6% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -15.5% (improving, 2yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
아이빔테크놀로지 ‘로봇암 이광자 생체현미경’ 의료기기 인증 획득
아이빔테크놀로지의 혁신적인 이동형 로봇암 이광자 생체현미경이 GMP 적합 인증 및 의료기기 제조 허가를 획득하여 기술 경쟁력과 시장 진출 가능성이 크게 향상되었다.
Positive
"베트남 이어 인니"…아이빔테크놀로지 유통계약
아이빔테크놀로지가 베트남에 이어 인도네시아에서도 유통계약을 체결하며 동남아시아 시장 확대에 성공했다.
Positive
아이빔테크놀로지, 반기 만에 전년매출 70% 달성
아이빔테크놀로지의 반기 매출이 전년 동기 대비 70% 증가하며 사상 최대 실적을 기록, 향후 연간 매출 경신 기대감 고조.

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 2,810Won52-week high 4,74552-week low 2,530

1-month return1.0Point

1m -9.94% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13